Compare · BSX vs RCLF
BSX vs RCLF
Side-by-side comparison of Boston Scientific Corporation (BSX) and Rosecliff Acquisition Corp I (RCLF): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BSX and RCLF operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BSX is the larger of the two at $60.90B, about 196.3x RCLF ($310.2M).
- BSX has hit the wire 2 times in the past 4 weeks while RCLF has been quiet.
- BSX has more recent analyst coverage (25 ratings vs 0 for RCLF).
- Company
- Boston Scientific Corporation
- Rosecliff Acquisition Corp I
- Price
- $62.06-5.52%
- $11.50-8.40%
- Market cap
- $60.90B
- $310.2M
- 1M return
- -11.05%
- -
- 1Y return
- -39.23%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 2
- 0
- Recent ratings
- 25
- 0
Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Rosecliff Acquisition Corp I
Rosecliff Acquisition Corp I, a blank check company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization/similar business combination with one or more businesses. The company was incoporated in 2020 and is based in New York, New York.
Latest BSX
- Boston Scientific Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Boston Scientific announces results for first quarter 2026
- SEC Form EFFECT filed by Boston Scientific Corporation
- SEC Form 424B3 filed by Boston Scientific Corporation
- Boston Scientific downgraded by Raymond James with a new price target
- Boston Scientific announces conference call discussing first quarter 2026 results
- Amendment: SEC Form S-4/A filed by Boston Scientific Corporation
- Boston Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
- HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
Latest RCLF
- Rosecliff Acquisition Corp I filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Rosecliff Acquisition Corp I filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form S-8 filed by Rosecliff Acquisition Corp I
- SEC Form SC 13G filed by Rosecliff Acquisition Corp I
- Rosecliff Acquisition Corp I filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Rosecliff Acquisition Corp I filed SEC Form 8-K: Leadership Update
- SEC Form EFFECT filed by Rosecliff Acquisition Corp I
- SEC Form 424B3 filed by Rosecliff Acquisition Corp I
- SEC Form S-1/A filed by Rosecliff Acquisition Corp I (Amendment)
- SEC Form S-1 filed by Rosecliff Acquisition Corp I